Related content

Therapeutic Advances in Biological Response Modifiers in the Treatment of Cutaneous T-Cell Lymphoma

By Vittorio C.C.   Rook A.H.   French L.E.   Shapiro M.   Lehrer M.S.   Junkinshopkins J.M.  

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 431-437

Adis International

Access to resources Recommend Favorite

Treatment of Cutaneous T Cell Lymphoma: Current Status and Future Directions

By Apisarnthanarax N.   Talpur R.   Duvic M.  

American Journal of Clinical Dermatology, Vol. 3, Iss. 3, 2002-03 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite

Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma

By Lyseng-Williamson Katherine A.   Yang Lily P.H.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite

Management of Refractory Early-Stage Cutaneous T-Cell Lymphoma

By Huber Margit A.  

American Journal of Clinical Dermatology, Vol. 7, Iss. 3, 2006-01 ,pp. : 155-169

Adis International

Access to resources Recommend Favorite

Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung

By Fe Medina M.   Kobinger G.P.   Rux J.   Gasmi M.   Looney D.J.   Bates P.   Wilson J.M.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 777-789

Elsevier

Access to resources Recommend Favorite